Alar Pharmaceuticals Inc. (6785.TWO)

TWD 126.5

(-1.94%)

Revenue Summary of Alar Pharmaceuticals Inc.

  • Alar Pharmaceuticals Inc.'s latest annual revenue in 2023 was 469.27 Million TWD , up 58559.0% from previous year.
  • Alar Pharmaceuticals Inc.'s latest quarterly revenue in 2024 Q2 was - TWD , down 0.0% from previous quarter.
  • Alar Pharmaceuticals Inc. reported a annual revenue of 800 Thousand TWD in annual revenue 2022, down 0.0% from previous year.
  • Alar Pharmaceuticals Inc. reported a annual revenue of - TWD in annual revenue 2021, down -100.0% from previous year.
  • Alar Pharmaceuticals Inc. reported a quarterly revenue of - TWD for 2024 Q1, down -100.0% from previous quarter.
  • Alar Pharmaceuticals Inc. reported a quarterly revenue of 468.47 Million TWD for 2023 Q4, up 58459.0% from previous quarter.

Annual Revenue Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Revenue of Alar Pharmaceuticals Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 469.27 Million TWD 58559.0%
2022 800 Thousand TWD 0.0%
2021 - TWD -100.0%
2020 600 Thousand TWD 0.0%
2019 - TWD 0.0%

Peer Revenue Comparison of Alar Pharmaceuticals Inc.

Name Revenue Revenue Difference
Allied Biotech Corporation 720.43 Million TWD 34.862%
GeneFerm Biotechnology Co., Ltd. 793.77 Million TWD 40.881%
Easywell Biomedicals, Inc. 271.62 Million TWD -72.763%
TTY Biopharm Company Limited 5.5 Billion TWD 91.476%
Synmosa Biopharma Corporation 5.14 Billion TWD 90.871%
Orient EuroPharma Co., Ltd. 4.59 Billion TWD 89.78%
Center Laboratories, Inc. 1.39 Billion TWD 66.336%
Tien Liang BioTech Co., Ltd. 459.99 Million TWD -2.017%
Orient Pharma Co., Ltd. 889.91 Million TWD 47.268%
InnoPharmax Inc. 46.07 Million TWD -918.54%
Johnson Chemical Pharmaceutical Works Co., Ltd. 606.71 Million TWD 22.653%
Excelsior Biopharma Inc. 771.56 Million TWD 39.179%
DV Biomed Co., Ltd. 1.53 Billion TWD 69.495%
Foresee Pharmaceuticals Co., Ltd. 195.03 Million TWD -140.605%
Handa Pharmaceuticals, Inc. 1.1 Billion TWD 57.583%
UniPharma Co., Ltd. 103.22 Million TWD -354.624%
Anxo Pharmaceutical Co., Ltd. 939.94 Million TWD 50.074%
Winston Medical Supply Co., Ltd. 709.07 Million TWD 33.819%
Mercury Biopharmaceutical Corporation 1.03 Million TWD -45328.074%
Bioray Biotech Co., Ltd 191.83 Million TWD -144.629%
TSH Biopharm Corporation Limited 810.91 Million TWD 42.131%